Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Stomach Neoplasms

NCT00084656 2022-04-14

Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma

Phase 2 Completed

77 enrolled 13 charts

Dermatologic

Uveal Melanoma, Melanoma

NCT02771340 2020-10-01

Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma

Phase 1 Completed

10 enrolled 10 charts

Dermatologic

Uveal Melanoma, Choroid Neoplasms

NCT01801358 2020-09-16

A Phase Ib/II Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma

Phase 1/2 Terminated

38 enrolled 31 charts

Dermatologic

Uveal Melanoma, Melanoma

NCT02889861 2020-07-27

IMCgp100-401 Rollover Study

Phase 2 Terminated

3 enrolled 14 charts

Dermatologic

Uveal Melanoma, Melanoma

NCT01974752 2017-01-05

SUMIT

Phase 3 Completed

152 enrolled 14 charts

Dermatologic

Uveal Melanoma, Neoplasm Metastasis

Clinical Trials

Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma

KZR-261 in Subjects With Advanced Solid Malignancies

A Study of SEA-CD40 Given With Other Drugs in Cancers

Study in Subjects With Small Primary Choroidal Melanoma

Safety & Activity of Controllable PRAME-TCR Therapy in Previously Treated AML/MDS or Metastatic Uveal Melanoma

A Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma

Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566

Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma

Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma

A Phase Ib/II Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma

IMCgp100-401 Rollover Study

SUMIT